Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 111
1992 139
1993 126
1994 148
1995 112
1996 126
1997 106
1998 113
1999 109
2000 131
2001 209
2002 199
2003 255
2004 270
2005 210
2006 202
2007 239
2008 311
2009 331
2010 371
2011 386
2012 416
2013 441
2014 466
2015 409
2016 407
2017 389
2018 437
2019 422
2020 516
2021 500
2022 460
2023 570
2024 270

Text availability

Article attribute

Article type

Publication date

Search Results

7,811 results

Results by year

Filters applied: . Clear all
Page 1
Myeloid sarcoma: more and less than a distinct entity.
Loscocco GG, Vannucchi AM. Loscocco GG, et al. Ann Hematol. 2023 Aug;102(8):1973-1984. doi: 10.1007/s00277-023-05288-1. Epub 2023 Jun 7. Ann Hematol. 2023. PMID: 37286874 Free PMC article. Review.
RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphoma.
Nowakowski GS, Yoon DH, Mondello P, Joffe E, Peters A, Fleury I, Greil R, Ku M, Marks R, Kim K, Zinzani PL, Trotman J, Sabatelli L, Waltl EE, Winderlich M, Sporchia A, Kurukulasuriya NC, Cordoba R, Hess G, Salles G. Nowakowski GS, et al. Ann Hematol. 2023 Jul;102(7):1773-1787. doi: 10.1007/s00277-023-05196-4. Epub 2023 May 12. Ann Hematol. 2023. PMID: 37171597 Free PMC article.
Heyde syndrome.
Suárez EU, Vidal-Laso R. Suárez EU, et al. Ann Hematol. 2023 Sep;102(9):2617-2618. doi: 10.1007/s00277-023-05299-y. Epub 2023 May 29. Ann Hematol. 2023. PMID: 37246201 No abstract available.
Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA.
Suzuki K, Wechalekar AD, Kim K, Shimazaki C, Kim JS, Ikezoe T, Min CK, Zhou F, Cai Z, Chen X, Iida S, Katoh N, Fujisaki T, Shin HJ, Tran N, Qin X, Vasey SY, Tromp B, Weiss BM, Comenzo RL, Kastritis E, Lu J. Suzuki K, et al. Ann Hematol. 2023 Apr;102(4):863-876. doi: 10.1007/s00277-023-05090-z. Epub 2023 Mar 2. Ann Hematol. 2023. PMID: 36862168 Free PMC article. Clinical Trial.
The roles of ubiquitination in AML.
Wei Z, Su L, Gao S. Wei Z, et al. Ann Hematol. 2023 Aug 21. doi: 10.1007/s00277-023-05415-y. Online ahead of print. Ann Hematol. 2023. PMID: 37603061 Review.
7,811 results